Beyond the Classroom
On this episode of Beyond the Classroom, Host Tyler Kern discussed future-ready learning with Ron Stefanski, Executive Director, Strategic Partnerships at Centric Learning, and Dr. Kevin Brown, Executive Director of Texas Association of School Administrators, which advocates on behalf of all the administrators in the state of Texas. As the son of two educators,…
Latest
Beyond the Classroom
Insights on the Past, Present and Future of Higher Education
Dr. James Smith is the 23rd President of East Michigan University. Dr. Smith’s education focus is on EMU students’ futures, not the past, because what they do in life with that education experience will make the world a better place. He joined host Tom Watkins to talk about his efforts and the education landscape as…
Beyond the Classroom
Beyond the Classroom: Rethinking What’s Normal in Education
In terms of the COVID-19 pandemic, an often-discussed notion is getting things back to normal. But in children’s education, what if normal was never good enough? What if, along with this pandemic, comes an opportunity to create a better normal? Technology and other learning tools could provide an accelerated and personalized learning experience for students….
Beyond the Classroom
Beyond the Classroom: Educational Reform in a Post-Pandemic World
Although no one can argue that the COVID-19 pandemic has set back education and student learning for months, if not years, there is still some good that has come out of our current situation. Now, educators better understand how to implement new technology into their lessons and how to better help students that may require…
Beyond the Classroom
Why Getting “Back To Normal” Isn’t Enough For Education
There has been a mantra of sort that has pushed leaders in all industries forward during the difficult moments of the COVID-19 pandemic: Back to normal. That has extended to the field of education, where getting kids back into the classroom and having things feel like they did at the end of 2019 has been…
Beyond the Classroom
Transforming The Future Of Education Through Student Engagement And Personalized Learning
As the world continues to wage a war against the coronavirus, American students struggle to keep up with their lessons and maintain a quality education. Although there are many teachers putting in their utmost effort to uplift their students, the fact is that there are still some that fall through the cracks of our educational…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…